Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphotransferases are a family of enzymes (EC 2.7) that catalyze the transfer of a phosphate group from a donor molecule (commonly ATP or phosphoenolpyruvate, PEP) to an acceptor molecule. The general reaction they catalyze is A-P + B -> A + B-P where A-P is the phosphoryl donor and B is the acceptor. The most well-known biological context for phosphotransferases is in bacteria, where they form part of the phosphoenolpyruvate-carbohydrate phosphotransferase system (PTS). This system couples sugar uptake with phosphorylation, using PEP as both an energy source and phosphoryl donor. Beyond transport, components of the bacterial PTS also participate in regulatory networks affecting carbohydrate metabolism, nitrogen/phosphorus utilization, and even virulence in some pathogens by interacting with non-PTS proteins depending on their phosphorylation state.
Phosphorylation of substrates
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphotransferase (PTase).